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3Abstract
Both cadmium (Cd2+) and nickel (Ni2+) are established environmental human carcinogens
without physiological functions found so far. Zinc (Zn2+) is not listed as a carcinogen, and
rather an essential element to humans. Metal ions have recently been shown to inhibit a
number of DNA repair proteins that use metals for their function and/or structure. In this
study, we report that Cd2+, Ni2+, and Zn2+ are able to inhibit the activity of a recombinant
human alkylpurine-DNA-N-glycosylase (hAPNG) towards a DNA oligonucleotide
containing a 1,N6-ethenoadenine (εA). This enzyme displays a broad substrate specificity
and does not require metal for its catalytic activity or structural integrity. At
concentrations starting from 50 to 1000 µM, both Cd2+ and Zn2+ showed metal-dependent
inhibitory effects on hAPNG catalytic activity. Ni2+ also inhibited the enzyme activity,
but to a lesser extent. Studies using HeLa cell-free extracts demonstrated similar patterns
of inactivation of the εA excision activity by the same metals. When a gel mobility shift
assay was used, binding of hAPNG to the substrate was not significantly affected by Cd2+
at concentrations that strongly inhibit the catalytic function, suggesting that the reduced
glycosylase activity is not due to altered APNG binding affinity to the substrate.  In this
study we also applied molecular dynamics (MD) simulations to gain insight into potential
interactions between metal ion and the hAPNG active site. Simulations using Zn2+
showed that the hAPNG active site could have a Zn2+ binding site, formed by several
catalytically important and conserved residues. Metal binding to such a site is expected to
interfere with the catalytic mechanism of this protein. These data suggest that inhibition
of hAPNG activity may contribute to metal mutagenicity, and could be the basis for the
previously reported metal inhibition of repair of alkylating agents-induced DNA damage
in cells.
4Introduction
In addition to multiple toxic effects from excessive exposure, many metals and their
compounds have been found to cause cancer in experimental animals and/or humans.
Two of the common toxic metals are cadmium (Cd2+) and nickel (Ni2+), which have no
physiological functions found to date. Exposure to these two metals and their compounds
has been an occupational hazard for a large number of workers involved in a variety of
related industrial fields (1-3). Given that both are ubiquitous in the environment and are
widely used in consumer products, the general population can be exposed through
multiple routes including food, water, air and skin contact (1-3). Environmental exposure
to cadmium is mostly through tobacco smoke for smokers and through food for non-
smokers.  Environmental pollution of cadmium also includes other sources such as fuel
combustion, nickel-cadmium batteries and contaminated soil. For nickel, although
inhalation occurs, the general population is mainly exposed through food. Dermal contact
with nickel alloys and other nickel products is also a route of exposure. Unlike these two
metals, zinc (Zn2+) is an essential element for numerous cellular proteins and normal
metabolic mechanisms, as well as for cell growth and division (4). However, over
exposure to this metal, resulting from occupational exposure or therapeutic
administration, can lead to a variety of toxic symptoms in both humans and animals (5).
5Both cadmium and nickel are classified as human carcinogens by the International
Agency for Research on Cancer (IARC) (2, 3) and the National Toxicology Program
(NTP) (1). Exposure to cadmium and its compounds has been associated with increased
cancer risk in human lung, prostate and testis (1, 2). Animal experiments support that
cadmium is a potent carcinogen as it induces malignancies in multiple organs including
lung, prostate, liver and kidney, as well as at sites of injection, depending on the route of
exposure (1, 2).  Likewise, nickel and its compounds are related to increased risk of lung
and nasal cancer in exposed workers and induce tumors in various organs of experimental
animals, such as lung, liver and kidney (1, 3). It is believed that the ionic form of metals
in their compounds is the active biological species. To date, although possible
carcinogenicity of zinc has been investigated through animal experiments and
occupational exposure, no sufficient evidence supports such a link.
Despite that the carcinogenicity of both cadmium and nickel has long been
established, the mechanisms by which they promote cancer transformation remain
unclear. A number of mechanisms have been proposed, including both genotoxic and
epigenetic effects of these metals on target cells. Recent evidence also points to that
inhibition of DNA repair processes is an important mechanism responsible for metal
induced mutagenesis and carcinogenesis (6-9). DNA repair is an essential cellular
mechanism for maintaining genomic integrity and its capacity is considered a crucial
6determinant of cancer susceptibility (10, 11). It contains several major pathways,
including base excision repair (BER), nucleotide excision repair (NER), and mismatch
repair (MMR), with each recognizing and repairing different types of DNA damage.
Studies on effects of metal ions showed both in vivo inhibition of repair of DNA damage
caused by specific agents and in vitro inactivation of individual enzymes in these repair
pathways. The target proteins identified include the NER component xeroderma
pigmentosum group A protein (XPA) (12, 13), the MMR recognition unit MSH2-MSH6
complex (14, 15), and several core enzymes in BER (16-19). In general, if metal
inactivates a DNA repair enzyme, cells would accumulate unprocessed mutagenic DNA
lesions or reaction intermediates that are normally processed by the enzyme, thereby
enhancing the genotoxicity of other DNA damaging agents, either from exogenous or
endogenous sources.
The BER pathway repairs a wide range of modified bases including alkylated,
oxidized and deaminated derivatives (10). It is initiated by damage-specific DNA
glycosylases that hydrolyze the glycosylic bond between a modified base and sugar,
generating an apurinic/apyrimidinic (AP) site. In the simplistic pathway of BER, AP site
is cleaved by AP endonuclease 1 (APE1), followed by DNA polymerase β (POLβ) which
removes the abasic sugar (dRpase activity) and fills the single nucleotide gap (DNA
polymerase activity). A DNA ligase seals the nick. Metals have been shown to inhibit
7cellular removal of both oxidative and alkylation DNA damage (20-23), which are
primarily repaired by the BER pathway. Two glycosylases that excise oxidized bases, the
bacterial formamidopyrimidine-DNA glycosylase (Fpg) and the murine 8-oxoG-DNA
glycosylase (mOGG1), are found to be targets for several metal ions (12, 16). Recently it
was also found that the human APE1 nuclease activity is inhibited by lead (Pb2+), iron
(Fe2+) and Cd2+ (17). In addition, POLβ and poly(ADP-ribose) polymerase-1 (PARP-1)
are both inactivated by Cd2+ and other metals (18, 19, 24).  To date, the studies on metal-
protein interactions in repair have mainly been focused on those zinc finger proteins (e.g.
XPA, Fpg and PARP-1) and other metal-requiring enzymes (e.g. APE1, ATPase of
MSH2-MSH6).
In this work, we were interested in whether the activity of the human alkylpurine-
DNA-N-glycosylase (APNG, also AAG and MPG) could also be affected by metal ions.
If so, what would be the possible mechanism for the metal-hAPNG interactions? Unlike
the proteins mentioned above, to our knowledge, hAPNG does not require a metal for its
function or structure. This is a well characterized enzyme with a broad substrate
specificity, excising a number of alkylated, exocyclic and deaminated bases formed by
exogenous agents or by endogenous processes (25-27). hAPNG and its homologues in
other species are known to function in mutation avoidance (26, 27). Its mechanism of
action has been proposed based on co-crystal structures (28, 29), in which a base flipping
8strategy is employed to dock a target base into the active site pocket. The catalytic
reaction is achieved through the active site bound water molecule, which is deprotonated
by nearby Glu125 to form a nucleophile for the attack on the C1’ of the sugar, resulting
in base release. In this study, we found that Cd2+, Ni2+ and Zn2+ at their micromolar
concentrations inhibit the activity of a recombinant hAPNG, or human cell-free extracts,
against DNA containing a 1,N6-ethenoadenine (εA). In addition, we used molecular
dynamics (MD) simulations to study the potential interactions between Zn2+ and hAPNG,
which revealed the Zn2+ affinity towards several catalytically important and conserved
residues in the hAPNG active site.
Experimental Procedures
Caution: Cadmium and nickel compounds are classified carcinogens and should be
handled with appropriate protection in accordance with NIH guidelines.
Chemicals, Proteins and Synthetic Oligonucleotides.  Cadmium chloride (CdCl2),
nickel chloride (NiCl2), and zinc chloride (ZnCl2) were all purchased from Aldrich-Sigma
(St. Louis, MO). Stock solutions at 0.1 mM concentration were prepared using distilled
and deionized water obtained from the Millipore ultrapurification system. Cell-free
extracts from HeLa S3 cells (Cell culture Center, Endotronics, Minneapolis, MN) were
9prepared as described previously (30). Truncated human recombinant protein APNG was
a generous gift from Dr. T.R. O’Connor (Beckman Research Institute, CA). Recombinant
hAPE1 was obtained from Enzymax (Lexington, KY). The 25-mer oligonucleotide
containing a single εA at 6th position from the 5’ side (5’-
CCGCTεAGCGGGTACCGAGCTCGAAT) was synthesized as described previously
(31). For an AP site-containing substrate, the same 25-mer sequence as above was
synthesized with a tetrahydrofuranyl (THF) residue at the 8th position by Operon, Inc.
(Alameda, CA). The complementary strand and the 5-mer and 7-mer size markers were
synthesized either with an Applied Biosystems Model 394 automated DNA synthesizer
or purchased from Operon. All modified and unmodified oligomers were HPLC- and/or
PAGE-purified.
DNA Binding Assay. To prepare a radiolabeled DNA substrate, the εA-containing
25-mer oligonucleotide was 5’-end labeled with [γ-32P] ATP (specific activity 6,000
Ci/mmol; 1 Ci = 37 GBq, Amersham Pharmacia Biotech, Piscataway, NJ) and T4
polynucleotide kinase (United States Biochemical, Cleveland, OH) according to standard
procedure. The 32P-labeled oligomer was subsequently annealed to a complementary
strand in a molar ratio of 1:1.5 by slow cooling from 80oC to room temperature. A gel
mobility shift assay described previously (30) was used to measure the binding activity of
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hAPNG for the εA-containing DNA duplex in the presence of CdCl2. Briefly, the
standard binding reactions contained 10 mM HEPES-KOH (pH 7.4), 100 mM KCl, 0.1
mM DTT, 10% glycerol, and 140 nM purified hAPNG in a total volume of 10 µl. CdCl2
was added to the system in two different ways: (1) Pre-incubation of hAPNG with CdCl2
on ice for 10 min before adding the 5’-end 32P-labeled duplex DNA (2 nM). The final
reaction mixture was incubated for 15 min at room temperature (~20 °C); (2) Incubation
of hAPNG and DNA duplex at room temperature for 10 min, then adding CdCl2 ,
followed by additional 5 min incubation. All reaction mixtures (5 µl) were immediately
loaded onto a 6% nondenaturing PAGE and electrophoresed for about 1 hr at 150 V using
1x TBE buffer.
DNA Glycosylase Assay. To test hAPNG-mediated cleavage of the same εA-
containing oligomer as used in the binding assay, a DNA cleavage assay was carried out as
described previously (30, 32). The reaction mixtures contained 2 nM 32P-end labeled
oligomer duplex in 10 mM HEPES-KOH (pH 7.4), 100 mM KCl, 0.1 mM DTT, and
varying amounts of purified hAPNG protein in a total volume of 10 µl. Metal ions were
pre-incubated with hAPNG for 10 min on ice prior to the addition of the substrate DNA.
Further incubations were carried out for 30 min at 37 °C. In reactions using cell-free
extracts, 0.5 µg of poly(dI-dC)•poly(dI-dC) (Amersham Pharmacia Biotech, Piscataway,
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NJ) was added to the reaction mixture as a nonspecific competitor. All the glycosylase
reactions were stopped by adding 5 µl alkaline buffer (300 mM NaOH, 90% formamide,
0.05% bromophenol blue), followed by heating the samples at 95-100 °C for 3 min.
Reaction products were resolved on a 7M urea 12% denaturing PAGE with a 5’ 32P-labeled
5-mer marker. The gel was subsequently dried and scanned with the Bio-Rad FX
Molecular PhosphorImager (Hercules, CA). For band quantitation, Quantity One software
(version 4.0.1) was used according to the manufacturer’s instructions. Data were plotted
using CA-Cricket Graph III (Computer Associates, Islandia, NY) and Microsoft Excel 98.
APE1 Nuclease Assay. To test the metal inhibition of hAPE1 activity toward a THF-
containing 25-mer oligonucleotide, a DNA cleavage assay as previously described (33) was
used to detect the single strand breaks. Briefly, the standard reaction was performed in a
mixture containing 2 nM 32P-end labeled oligomer duplex, 20 mM Tris-HCl (pH 7.4), 100
mM KCl, 1 mM MgCl2 and varying concentrations of ZnCl2 or CdCl2 in a total volume of
10 µl. Initially, hAPE1 (0.38 nM) was pre-incubated with a metal ion for 10 min on ice.
After the addition of the 32P-end labeled DNA substrate, the reaction was incubated at 37oC
for 10 min, stopped by addition of an equal volume of a gel loading buffer containing 50
mM EDTA, 90% formamide and 0.05% bromophenol blue. Gel electrophoresis, scanning
and data analysis were performed as described above.
12
Molecular Dynamics (MD) Simulations. The starting coordinates for hAPNG were
obtained from the hAPNG complexed to εA-containing DNA (PDB code id: 1f4r). All
simulations were carried out using the SANDER module of Amber 8.0 (34) molecular
modeling package with Cornell et al. force field (35). The force field parameters for the
Zn2+ atom were used from the Amber data set. Initially 4 Cl- ions were added to neutralize
the system. Then, for the starting conformations, 10 Zn2+ ions were randomly placed in
the vicinity of the active site of the protein. Five sets of the initial models were prepared
with different distribution of the metal ions around the active site. Figure 6 shows an
example of one of the initial models.   For each model the simulation consists of two
steps, equilibration and production. During the equilibration the system was minimized
for the 200 steps to remove any close contacts and relax atomic positions.  The system
was then gradually heated for 20 ps from 10 to 310 K using Langevin dynamics for
temperature regulation while holding the solute fixed with harmonic restraints of 10 kcal
mol -1Å-1. Unrestrained production MD runs were initiated after the equilibration steps
and were carried out at 310 K for 1 ns. All calculations were performed with implicit
solvent using generalized born simulations (GBobc) using Bondi radii set (36, 37). The
cutoff distance was set at 50 Å and a 1 fs time step was used for all simulations. The
atomic coordinates were stored every 0.25 ps.
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MD trajectories were processed using the CARNAL module of the Amber 8.0
package and visualized using VMD 1.8.3 software (38).
Results and Discussion
Metals have long been known to be carcinogenic to humans and/or animals. Although
many genotoxic and epigenetic effects have been identified for various metals, the
precise mechanisms underlying such effects are still largely unknown. Recent data are
emerging to suggest that metal-induced inhibition of DNA repair processes could play an
important role, since impaired DNA repair capacity would directly lead to increased
frequency of either spontaneous or environmentally induced mutagenesis, ultimately
resulting in cancer. The reported weak mutagenic potential of metals per se and their
comutagenicity with other genotoxic agents support such a notion.
As described in the Introduction, previous biochemical studies have identified several
repair proteins that are targets for specific metal ions and their mechanisms of
interactions proposed. In this study, we were interested in whether the activity of
hAPNG, a BER enzyme that does not apparently require a metal for its function or
structure, could be affected by the metal ions. In vitro, this enzyme is known to possess a
broad substrate range which may have important biological implications (25-27). Given
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that it is a major glycosylase activity excising alkylation damage, data obtained on metal
inhibition of its activity may aid in understanding the molecular basis for the previously
observed metal induced reduction in repair of DNA damage in cells exposed to alkylating
agents (20, 21). In addition, available X-ray crystal structures of hAPNG complexed to
DNA (28, 29) provided a structural framework for our modeling studies.    
Inhibition of hAPNG Activity by Cd2+, Zn2+ and Ni2+. Using an in vitro
oligonucleotide-based cleavage assay, we have previously studied hAPNG activity
towards the εA adduct and its analogues (39-41). In this work, to investigate possible
inhibition of hAPNG by common metals, the same assay was utilized to test the activity
of a recombinant hAPNG towards an oligonucleotide containing an εA, which is a
product formed from the reaction of DNA with environmental carcinogens such as vinyl
chloride or by internal metabolic processes such as lipid peroxidation (25). The
glycosylase activity was tested at micromolar Cd2+, Ni2+, or Zn2+ concentrations at 37oC
for 30 min, followed by addition of an alkaline solution containing NaOH/formamide to
cleave the resulting AP site. Separation of intact oligonucleotide (25-mer) and cleaved
product (5-mer) was achieved with denaturing PAGE (details in the Experimental
Procedures).
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As shown in Figure 1, in the presence of Cd2+ or Zn2+, intensities of the expected 5-
mer cleavage products (indicated by an arrow) decreased in a metal-dependent manner,
and  hAPNG lost more than 90% of activity when the concentration of both metal ions in
the reaction mixture reaches 500 µM (Figure 2). When treated with Ni2+, the cleavage
activity of hAPNG also exhibited a concentration-dependent inhibition but to a lesser
extent (Figures 1 and 2). For all three metals, partial reduction of hAPNG activity could
be seen at their initial concentration, 50 µM, at which Zn2+ is the most efficient inhibitor
with an approximately 50% reduction of the hAPNG activity (Figure 2).
A key issue in these studies is to assess metal-induced effects at their environmentally
and/or biologically relevant concentrations. For example, the concentrations of Cd2+ in
organs/tissues of healthy unexposed humans can be in the low to middle micromolar
ranges. Studies showed that the levels of Cd2+ reach 12-28 µM in the prostate, 0.9-6 µM
in lungs, and significantly higher levels in kidneys and liver (1, 42-44). Under certain
circumstances, levels of Cd2+ could be significantly higher in cells. For instance, for
cigarette smokers, the Cd2+ concentrations can be 2-4 fold higher than in the non-
smokers. Normally most of cellular Cd2+ is bound to an intracellular protein called
metallothionein (45). However, under oxidative stress, Cd2+ may be released from this
protein, leading to higher levels in the cell. Moreover, cadmium has a fairly long
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biological half-life (10-30 years), thus resulting in age-dependent accumulation in
organisms. In this work, the inhibition of APNG activity was observed at concentrations
as low as 50 µM for all three metals tested. Based on the amounts of Cd+2 in tissues
described above, it is reasonable to speculate that such a level is biologically relevant.
A similar inhibition pattern was also observed when HeLa cell-free extracts were
tested for activity against εA in the presence of Cd2+, Zn2+ or Ni2+ (Figure 3). Since it was
shown in our previous work the εA cleavage activity was virtually undetectable in tissues
of APNG-knockout mice (40), the εA excision activity detected in Figure 3, using the
same enzymatic assay, should reflect the activity of APNG in these extracts. Such
experiments using cell-free extracts allow for assessment of any difference in inhibition
between purified enzyme and cell-free extracts, as metal ions may interact with other
protein component(s) in the extracts. In this study, the results obtained from using cell-
free extracts are consistent with those from recombinant APNG with regard to metal
specificity.
To investigate the effect of metal ions on hAPNG binding to the εA substrate, Cd2+ at
125 to 2000 µM was added to binding reactions in two different ways. In Figure 4,
Experiment 1, 140 nM hAPNG was pre-incubated with Cd2+ for 10 min prior to the
addition of εA-25-mer duplex. The result shows that hAPNG binding to this duplex was
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not affected at concentrations ≤ 250 µM, slightly affected at 500 µM, suggesting that the
greatly reduced catalytic activity of hAPNG observed in this range (Figure 2) is not due
to altered APNG binding affinity for its substrate DNA. In Figure 4, Experiment 2,
hAPNG and εA-25mer duplex were first incubated for 10 min at room temperature,
followed by addition of Cd2+ and further incubation for 5 min. Under this treatment, the
extent of hAPNG binding to the DNA was not dramatically affected by the presence of
Cd2+ at concentrations ≤ 500 µM, indicating that Cd2+ could not disrupt the already
formed protein-DNA complex. In addition to proteins, Cd2+ has the ability to bind to
certain sites in DNA duplex, such as the N7 atoms of guanine residues, thus slightly
destabilizing the DNA structure (46, 47). In general, destabilization of the DNA helix
could affect the initial formation of the hAPNG-DNA complex. However, our binding
experiments showed that hAPNG binding to the DNA substrate is not affected
significantly or proportionally at metal concentrations that exhibit catalytic inactivation.
These results support the direct interaction between the metal and the protein catalytic
element/function.
Similar to other repair proteins targeted by metals, the biological consequences of
hAPNG inhibition identified from these biochemical experiments have yet to be
determined. APNG is the major DNA glycosylase that removes cytotoxic and mutagenic
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alkylated bases (26, 27). Previous studies using mammalian cells have shown that metals
such as Cd2+ inhibit repair of DNA damage formed by alkylating agents such as methyl
methanesulfonate (MMS) and N-methyl-N-nitrosourea (MNU) (20, 21). These chemicals
are potent human carcinogens and capable of forming a variety of alkylated bases, many
of which are recognized and excised by the APNG protein. Therefore, it is reasonable to
propose that the inhibition of APNG activity by metals contributes to such metal induced
decrease in the cellular repair of alkylation DNA damage.
It was recently reported by McNeill et al. (17) that Pb2+, Fe2+ and Cd2+ inhibit the
nuclease activity of hAPE1, a pivotal enzyme in BER that processes the AP sites
generated by DNA glycosylases or formed spontaneously (10, 48). Therefore, both
hAPNG glycosylase activity and hAPE1 nuclease activity can be inhibited in vitro by the
same metal ion, Cd2+. Since APE1 is responsible for >95% of the total AP endonuclease
activity in human cell extracts (49), it could be argued that the inhibition of APE1 by
Cd+2 in vivo would block the majority of BER capacity regardless of whether APNG is
inhibited or not. However, the inactivation of APE1 yields accumulation of AP sites,
whereas inhibition of the APNG activity would result in accumulation of a variety of
modified base lesions, which may cause differential effects on DNA structure and
function than an AP site. In the case of Ni2+, it inhibits the activity of hAPNG (this work)
but not that of hAPE1 (17), showing a different inhibition specificity than Cd+2. In this
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study, we were also curious about whether the Zn2+ ion inhibits the AP endonuclease
activity of hAPE1. As shown in Figure 5, at the concentrations tested, Zn+2 showed a
metal-dependent inhibition of the activity of hAPE1 towards DNA containing a synthetic
AP site THF, indicating that Zn2+, similar to Cd+2, can also suppress the activity of both
proteins. It should be noted that, in the case of APE1 inhibition, BER may be able to
bypass it through another enzyme, the polynucleotide kinase (PNK), as shown for the
human endonuclease VIII-like glycosylase 1 (NEIL1) (50). However, caution should be
exercised in extrapolating data from in vitro to in vivo, as many factors could affect the
reaction conditions and pathway regulations when metal inhibition takes place in cells.
Molecular Dynamics Simulations of Interaction of hAPNG with Zn2+. Previous
studies suggested that inhibition of repair proteins is mainly associated with displacement
by environmental metals of the original metal ions utilized by proteins for their function
or structure. In interactions with zinc finger proteins such as XPA (19, 51, 52), metal ions
like Cd2+ and Ni2+ have a high affinity for the –SH groups and can replace or compete
with Zn2+ at the Cys-His motifs. Simultaneous treatment with Zn2+ can partially prevent
inhibition by Cd2+ or Ni2+. For hAPE1, which requires Mg2+ in its catalytic mechanisms
proposed from structural studies (53-55), the inhibitory metals may occupy the Mg2+
binding sites but with different coordination chemistry or ligand preferences, thus
disrupting the Mg2+-dependent catalysis (17). The mechanism of inhibition of the ATPase
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activity of MSH2-MSH6 by Cd2+ is not clear, even though Mg2+ is an element at the
ATPase active site. It was proposed that Cd2+ could bind to other site(s) in these proteins
through coordination with specific residues in tetrahedral geometries (14, 15).
To gain insight into the mechanism of hAPNG-metal interaction, we performed MD
simulations using Zn2+ as a representative cation.  The 3D protein structure was based on
the coordinates from the previously reported crystal structure of hAPNG (29). As shown
in Figure 6, the Zn2+ ions, when located in a close proximity to the enzyme active site,
have the ability to protrude into the active site, showing higher affinity for the negatively
charged groups of the residues lining the cavity walls. In 3 out of 5 starting
conformations, one of the Zn2+ ions initially interacted with the negatively charged main
chain carbonyl groups of Gly 249 and Val 248. This interaction took place after first 20
ps of MD simulation. However, the position of the metal was rather unstable at this site
and it further moved toward the anionic patch formed by the side chain of Glu 125 and O
from the hydroxyl group of Tyr 127. The position of the metal ion was stabilized at this
site for the rest of the simulation. In the final conformation, the Zn2+ ion is coordinated
with the side chains of Glu 125 and Tyr 127, the main chain carbonyl group of Val 248
and the O of the active site water molecule, thus providing a template for the tetrahedral
coordination of the metal ion (Figure 7). Such a tetrahedral coordination is a preferred
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coordination for Zn2+ among 309 structures analyzed from the Metalloprotein Database
and Browser (MBD) (56).
Based on the above data, we propose that the hAPNG active site pocket could have a
binding site for the positively charged metal ions such as Zn2+ or Cd2+. However, in order
for metal ions to bind to this site they have to be close to the active site, which can be
achieved at elevated concentrations of the metal. For example, in our biochemical
experiments shown in Figure 1, at 50 µM Zn2+ and 350 nM hAPNG, the ratio of the metal
to protein is 142:1, which is a substantial excess of the metal ions over the APNG
molecules in solution.  The binding of the metal to the conserved active site residues such
as Glu 125 and Tyr 127 is expected to interfere with the catalytic mechanism of hAPNG.
It has previously been proposed that the Glu 125 abstracts a proton from a water
molecule, thus generating nucleophile (OH¯) which attacks the glycosylic bond (28, 29).
Displacement of water at the active site by a positively charged metal or precluding the
water interaction with Glu 125 could result in the loss of the essential nucleophile for the
catalytic reaction.
In our simulation studies Zn2+ was used as a model ion, since it showed an efficient
inactivation of the hAPNG activity (Figures 1 and 2) and its parameters are available in
Amber force field. As far as Cd2+ is concerned, it is known that Cd2+ has a high affinity
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toward Zn2+ binding sites in metalloproteins motifs (57-59). Analysis of the Cd2+ binding
sites in metalloproteins suggested that this metal has a preference for the Cys, Glu, Asp
and His residues in tetrahedral geometries (8, 56), thus suggesting that the Zn2+ binding
site identified in our modeling could also be bound by Cd2+. The lower inhibition of the
hAPNG activity by Ni2+ relative to Cd2+ and Zn2+ (Figure 2) may be correlated with the
data showing that Ni2+ prefers coordination through 5 to 6 ligands, based on the analysis
of available structures in MDB (56), while the hAPNG metal binding site proposed from
our modeling favors tetrahedral coordination.
Conclusion
Inhibition of DNA repair has recently been considered as a contender for the
mechanism underlying the metal-induced mutagenesis and carcinogenesis. Consistent
with this, the work reported here indicates that Cd2+, Ni2+ and Zn2+ can inhibit the
catalytic activity of hAPNG at submillimolar concentrations, which could enhance
gentotoxic potential of a variety of compounds such as alkylating agents. Although in
vitro work on metal inhibition allows mechanistic insight into operation of this enzyme in
cellular repair processes, further in vivo studies are needed to assess the biological
implications of these biochemical inhibitory effects, such as the role of APNG in metal
induced suppression of repair of DNA damage caused by alkylating agents in cells.
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Mechanistically, the finding that a non-metal requiring repair enzyme like hAPNG can be
inhibited by metal ions is worth to be explored with other enzymes that have a similar
nature. Molecular dynamics simulations provide a first insight into potential interactions
between metal ion and the active site of hAPNG. Future work towards understanding the
chemical details of such interactions would be essential for elucidating the precise
mechanism of metal inhibition.
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Figure legends
Figure 1.  Cleavage assay of recombinant hAPNG against a 25-mer oligonucleotide
containing an εA adduct under various concentrations of metal ions. Standard enzymatic
reactions were carried out at 37oC for 30 min under conditions described in Experimental
Procedures. The reactions were terminated by addition 5 µl of an alkaline solution
(NaOH/formamide) to 10 µl of the reaction mixture, followed by heating samples
at100oC for 3 min to cleave the AP sites generated by hAPNG. The arrow indicates the
migration position of the 5-mer marker which is the expected position of a cleavage
product.  Lane 1 contained buffer only. Lane 2 contained purified hAPNG without a
metal ion.
Figure 2. Relative cleavage activity of hAPNG towards εA under various concentrations
of metal ions. For quantitation of the bands corresponding to the cleaved product and the
remaining uncut substrate, band areas on the phosphorimage were measured by Quantity
One software (version 4.0.1). The activity of hAPNG for εA without the presence of
metal ions was treated as 100%. Experimental conditions were as described in Figure 1.
The data were an average value of three parallel experiments.
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Figure 3. Cleavage assay of HeLa cell-free extracts toward the εA-containing
oligonucleotide under various concentrations of metal ions. The reactions were carried
out at 37oC for 1 hr under conditions described in Experimental Procedures and stopped
by addition of 5 µl NaOH/formamide and heating at 95oC for 3 min to cleave the AP
sites. The latter procedure is normally not required for assaying glycosylase-mediated
cleavage since HeLa cell-free extracts contain sufficient AP endonuclease activity to
hydrolyze the AP sites. However, in this study, the original APE activity in extracts could
be inhibited by metal ions.
Figure 4. Gel mobility shift assay of hAPNG binding to the 25-mer oligonucleotide
containing an εA adduct. Top gel image: DNA bound to hAPNG and unbound DNA
were labeled as "Bound" and "Free DNA", respectively. Experiment 1: Pre-incubation of
140 nM hAPNG with varying concentrations of Cd2+ on ice for 10 min, followed by
addition of 2 nM 32P-labelled DNA and incubation at room temperature (~20oC) for 15
min. Experiment 2: Incubation of 140 nM hAPNG with 2 nM DNA at room temperature
for 10 min followed by addition of Cd2+ and further incubation for 5 min. All reactions
were immediately loaded onto a 6% non-denaturing PAGE. Bottom bar graphs: The
bands labeled “Bound” and “Free DNA” in both Experiments 1 and 2 were scanned and
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plotted as % hAPNG binding to the DNA substrate. The left graph is corresponding to
Experiment 1 in top gel image and the right graph is corresponding to Experiment 2.
Figure 5. Effect of Zn2+ and Cd2+ on the AP activity of hAPE1 using the 25-mer
oligonucleotide containing a THF. Pre-incubation of hAPE1 with a metal ion and
standard enzymatic reactions were described in Experimental Procedures. The arrow on
the right side of the top gel image indicates the 7-mer cleavage product from hAPE1. The
bottom bar graph shows the relative cleavage activity of hAPE1 under various Zn2+
concentrations. For comparison, Cd2+, which is known to inhibit hAPE1 (17), was tested
in parallel with Zn2+ under the same conditions. The activity of APE1 without the
presence of a metal ion is designated as 100%.
Figure 6.  Representative starting conformation used for the MD simulation of hAPNG
with 10 Zn2+ cations distributed around the active site. The catalytically important active
site residues are colored by atom. Zn2+ cations are shown as light blue spheres. Cl-
counterions are shown as green spheres.
Figure 7. The position of the Zn2+ ion at the hAPNG active site as determined by 1ns MD
simulations. The Zn2+ ion (shown in light blue sphere) is coordinated by the side chains
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of Glu 125 and Tyr 127, and the main chain carbonyl of Val 248. In addition, the metal
ion is coordinated by the O of the active site water molecule.
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